Tofacitinib: A novel oral treatment for rheumatoid arthritis

Submitted by Dr S. Patel on 6 September 2014

Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients. 

http://www.hopkinsarthritis.org/arthritis-news/tofacitinib-fda-approved-oral-biologic-for-rheumatoid-arthritis/

Changed
06/Sep/2014
Community
Muscle, Bone and Joint (earlier named Arthritis)
Condition
Arthritis

Stories

  • , , , , , ,
    Types of Arthritis
    Different types of arthritis Osteoarthritis (OA) OA is the most common type of arthritis. It involves wear and tear damage to your joint's cartilage — the hard, slick coating on the ends of bones. This wear and tear can occur over many years, or it can be hastened by a joint injury or infection. It appears most frequently appears in the weight-bearing joints like hips, knees and hands. Commonly seen in old age.                  Rheumatoid arthritis…
  • Not a “useless wife”
    Chennai-based R. Radha did not let rheumatoid arthritis (or negative comments) stop her from leading a full life as a wife, mother and grandmother. Here, she talks about the treatments, therapies and determination that helps her fight her condition. My struggle with rheumatoid arthritis started when I was 22 years old. It was November 1956. Every day I used to wake up early in the morning to make coffee. But that morning, my entire body, especially the joints in my…